Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
SmileDirectClub call volume above normal and directionally bullish » 14:45
10/19/21
10/19
14:45
10/19/21
14:45
SDC

SmileDirectClub

$6.07 /

+0.465 (+8.30%)

Bullish option flow…

Bullish option flow detected in SmileDirectClub with 116,377 calls trading, 1.1x expected, and implied vol increasing almost 15 points to 120.06%. 10/22 weekly 6 calls and 10/29 weekly 6 calls are the most active options, with total volume in those strikes near 45,900 contracts. The Put/Call Ratio is 0.09. Earnings are expected on November 8th.

ShowHide Related Items >><<
SDC SmileDirectClub
$6.07 /

+0.465 (+8.30%)

SDC SmileDirectClub
$6.07 /

+0.465 (+8.30%)

09/30/21 Credit Suisse
SmileDirectClub assumed with an Outperform at Credit Suisse
09/20/21 Stifel
Stifel cuts SmileDirectClub to Hold on market share loss, growth uncertainty
09/20/21 Stifel
SmileDirectClub downgraded to Hold from Buy at Stifel
08/13/21
Fly Intel: Top five analyst downgrades
SDC SmileDirectClub
$6.07 /

+0.465 (+8.30%)

  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$6.07 /

+0.465 (+8.30%)

SDC SmileDirectClub
$6.07 /

+0.465 (+8.30%)

SDC SmileDirectClub
$6.07 /

+0.465 (+8.30%)

Recommendations
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS » 13:32
10/19/21
10/19
13:32
10/19/21
13:32
AZN

AstraZeneca

$60.31 /

+1.03 (+1.74%)

UBS analyst Michael…

UBS analyst Michael Leuchten raised the firm's price target on AstraZeneca to 10,000 GBp from 9,200 GBp and keeps a Buy rating on the shares.

ShowHide Related Items >><<
AZN AstraZeneca
$60.31 /

+1.03 (+1.74%)

AZN AstraZeneca
$60.31 /

+1.03 (+1.74%)

10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
09/28/21 Oppenheimer
Zentalis initiated with an Outperform at Oppenheimer
AZN AstraZeneca
$60.31 /

+1.03 (+1.74%)

AZN AstraZeneca
$60.31 /

+1.03 (+1.74%)

AZN AstraZeneca
$60.31 /

+1.03 (+1.74%)

AZN AstraZeneca
$60.31 /

+1.03 (+1.74%)

Hot Stocks
Adagio Therapeutics announces in vitro data related to mAb ADG20 » 06:42
10/19/21
10/19
06:42
10/19/21
06:42
ADGI

Adagio Therapeutics

$33.58 /

+1.4 (+4.35%)

Adagio Therapeutics…

Adagio Therapeutics announced new in vitro data demonstrating retained neutralizing activity of its monoclonal antibody, or mAb, ADG20, against a diverse panel of circulating SARS-CoV-2 variants, including the newly emerged Lambda and Mu variants. Notably, findings show that ADG20 demonstrated potent in vitro neutralizing activity against all SARS-CoV-2 variants of concern tested, including those with reduced susceptibility to mAb products currently available under Emergency Use Authorization, or EUA, or in late-stage development. These data will be presented during a poster session at the 2021 ISIRV-WHO Virtual Conference, which is being held October 19-21, 2021. In addition, Adagio will present an encore poster highlighting recently announced data from the company's ongoing Phase 1 trial of ADG20 in healthy participants. In addition to the Phase 1 healthy participant trial, Adagio is advancing two ongoing global Phase 2/3 trials with ADG20, a treatment trial, or STAMP, and a prevention trial, or EVADE. The company anticipates submitting an EUA application to the FDA for ADG20 in the Q1 of 2022.

ShowHide Related Items >><<
ADGI Adagio Therapeutics
$33.58 /

+1.4 (+4.35%)

ADGI Adagio Therapeutics
$33.58 /

+1.4 (+4.35%)

10/01/21 Stifel
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel
08/31/21
Fly Intel: Top five analyst initiations
08/31/21 Guggenheim
Adagio Therapeutics initiated with a Buy at Guggenheim
08/31/21 Stifel
Adagio Therapeutics initiated with a Buy at Stifel
ADGI Adagio Therapeutics
$33.58 /

+1.4 (+4.35%)

  • 06
    Aug
ADGI Adagio Therapeutics
$33.58 /

+1.4 (+4.35%)

Monday
Initiation
Wells Fargo starts telehealth 'one-stop shop' Teladoc at Overweight » 16:24
10/18/21
10/18
16:24
10/18/21
16:24
TDOC

Teladoc

$136.23 /

+0.875 (+0.65%)

Wells Fargo analyst…

Wells Fargo analyst Stephen Baxter initiated coverage of Teladoc with an Overweight rating and $156 price target. Teladoc has evolved over the past few years into a virtual care platform and has become "by far the largest and most scaled company in the telehealth space," Baxter tells investors. He likes that Teladoc has exposure to several key telehealth product categories and views the company as "well positioned to support the virtual care ambitions of its client base as something close to a one-stop shop," he added. He expects 20%-plus organic revenue growth for at least the next five years, the analyst added.

ShowHide Related Items >><<
TDOC Teladoc
$136.23 /

+0.875 (+0.65%)

TDOC Teladoc
$136.23 /

+0.875 (+0.65%)

09/20/21 KeyBanc
New CEO 'certainly a positive surprise' for NextGen shareholders, says KeyBanc
09/15/21 RBC Capital
Teladoc long-term growth outlook intact, says RBC Capital
08/09/21 Cowen
Teladoc price target lowered to $188 from $240 at Cowen
TDOC Teladoc
$136.23 /

+0.875 (+0.65%)

TDOC Teladoc
$136.23 /

+0.875 (+0.65%)

TDOC Teladoc
$136.23 /

+0.875 (+0.65%)

TDOC Teladoc
$136.23 /

+0.875 (+0.65%)

Periodicals
Pfizer, Moderna forecasted to make $93.2B in combined sales in 2022, FT reports » 06:26
10/18/21
10/18
06:26
10/18/21
06:26
PFE

Pfizer

$41.49 /

-0.18 (-0.43%)

, BNTX

BioNTech

$247.70 /

-2.44 (-0.98%)

, MRNA

Moderna

$324.02 /

-7.73 (-2.33%)

, AZN

AstraZeneca

$60.22 /

+0.52 (+0.87%)

, JNJ

Johnson & Johnson

$161.35 /

+1.27 (+0.79%)

BioNTech (BNTX) / Pfizer…

BioNTech (BNTX) / Pfizer (PFE) and Moderna (MRNA) is projected to generate $93.2B in combined sales in 2022, nearly double the amount of revenue compared to 2021, Jamie Smith of The Financial Times reports, citing projections by Airfinity. Airfinity also suggested the two vaccines will control three-quarters of the non-Chinese COVID-19 vaccine market next year. AstraZeneca (AZN), Johnson & Johnson (JNJ), Russia's Sputnik V, and any other new entrants make up the remainder of the market, which is forecasted to value $124B next year, which is also double the revenue of this year, The Financial Times reports, citing the forecasts by Airfinity. "We expect continued high sales levels in 2022 as countries seek continued protection and low- and middle-income countries seek similar vaccination levels to what many high-income countries have achieved," Rasmus Bech Hansen, Airfinity's CEO, said, according to The Financial Times. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
MRNA Moderna
$324.02 /

-7.73 (-2.33%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
09/28/21 Oppenheimer
Zentalis initiated with an Outperform at Oppenheimer
JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

Over a week ago
On The Fly
Short Interest Report: New York Times shorts squeezed by breakout » 16:33
10/15/21
10/15
16:33
10/15/21
16:33
BGFV

Big 5 Sporting

$23.95 /

-0.06 (-0.25%)

, FUV

Arcimoto

$10.33 /

-0.17 (-1.62%)

, LXU

LSB Industries

$9.25 /

-0.315 (-3.29%)

, MSTR

MicroStrategy

$750.46 /

+24.31 (+3.35%)

, PHAS

PhaseBio

$3.98 /

-0.02 (-0.50%)

, BOLT

Bolt Biotherapeutics

$13.52 /

-0.03 (-0.22%)

, NYT

New York Times

$53.15 /

-1.16 (-2.14%)

, SDC

SmileDirectClub

$5.53 /

-0.21 (-3.66%)

Welcome to this week’s…

ShowHide Related Items >><<
SDC SmileDirectClub
$5.53 /

-0.21 (-3.66%)

PHAS PhaseBio
$3.98 /

-0.02 (-0.50%)

NYT New York Times
$53.15 /

-1.16 (-2.14%)

MSTR MicroStrategy
$750.46 /

+24.31 (+3.35%)

LXU LSB Industries
$9.25 /

-0.315 (-3.29%)

FUV Arcimoto
$10.33 /

-0.17 (-1.62%)

BOLT Bolt Biotherapeutics
$13.52 /

-0.03 (-0.22%)

BGFV Big 5 Sporting
$23.95 /

-0.06 (-0.25%)

BGFV Big 5 Sporting
$23.95 /

-0.06 (-0.25%)

08/04/21 Lake Street
Big 5 Sporting price target raised to $31 from $26 at Lake Street
05/05/21 Lake Street
Big 5 Sporting price target raised to $26 from $19 at Lake Street
03/03/21 Lake Street
Big 5 Sporting price target raised to $19 from $16 at Lake Street
01/14/21 Lake Street
Lake Street bumps Big 5 Sporting price target to $16 after Q4 pre-announcement
FUV Arcimoto
$10.33 /

-0.17 (-1.62%)

09/10/21
Fly Intel: Top five analyst initiations
09/10/21 Alliance Global Partners
Arcimoto initiated with a Buy at Alliance Global Partners
04/01/21
Fly Intel: Top five analyst downgrades
04/01/21 H.C. Wainwright
Arcimoto downgraded to Neutral from Buy at H.C. Wainwright
LXU LSB Industries
$9.25 /

-0.315 (-3.29%)

MSTR MicroStrategy
$750.46 /

+24.31 (+3.35%)

08/24/21 Jefferies
MicroStrategy price target raised to $700 from $640 at Jefferies
08/20/21 Citi
Citi places Sell rating on MicroStrategy under review over bitcoin
07/30/21 Canaccord
MicroStrategy price target lowered to $780 from $920 at Canaccord
07/30/21 BTIG
MicroStrategy price target raised to $950 from $850 at BTIG
PHAS PhaseBio
$3.98 /

-0.02 (-0.50%)

10/13/21 Stifel
PhaseBio resumed with a Buy at Stifel
05/14/21 William Blair
PhaseBio remains 'significantly undervalued,' says William Blair
03/16/21 Needham
PhaseBio price target raised to Street high $19 at Needham
BOLT Bolt Biotherapeutics
$13.52 /

-0.03 (-0.22%)

03/02/21
Fly Intel: Top five analyst initiations
03/02/21 SVB Leerink
Bolt Biotherapeutics initiated with an Outperform at SVB Leerink
03/02/21 Morgan Stanley
Bolt Biotherapeutics initiated with an Overweight at Morgan Stanley
03/02/21 Stifel
Bolt Biotherapeutics initiated with a Buy at Stifel
NYT New York Times
$53.15 /

-1.16 (-2.14%)

05/06/21 JPMorgan
New York Times shares may be range-bound near term, says JPMorgan
03/18/21 Guggenheim
Guggenheim upgrades News Corp. to Buy, sees 'significant value' to be unlocked
11/09/20 Evercore ISI
New York Times upgraded to Outperform from In Line at Evercore ISI
10/27/20 JPMorgan
New York Times selloff brings attractive entry point, says JPMorgan
SDC SmileDirectClub
$5.53 /

-0.21 (-3.66%)

09/30/21 Credit Suisse
SmileDirectClub assumed with an Outperform at Credit Suisse
09/20/21 Stifel
Stifel cuts SmileDirectClub to Hold on market share loss, growth uncertainty
09/20/21 Stifel
SmileDirectClub downgraded to Hold from Buy at Stifel
08/13/21
Fly Intel: Top five analyst downgrades
SDC SmileDirectClub
$5.53 /

-0.21 (-3.66%)

PHAS PhaseBio
$3.98 /

-0.02 (-0.50%)

NYT New York Times
$53.15 /

-1.16 (-2.14%)

MSTR MicroStrategy
$750.46 /

+24.31 (+3.35%)

LXU LSB Industries
$9.25 /

-0.315 (-3.29%)

FUV Arcimoto
$10.33 /

-0.17 (-1.62%)

BOLT Bolt Biotherapeutics
$13.52 /

-0.03 (-0.22%)

  • 18
    Mar
  • 05
    Feb
  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$5.53 /

-0.21 (-3.66%)

NYT New York Times
$53.15 /

-1.16 (-2.14%)

MSTR MicroStrategy
$750.46 /

+24.31 (+3.35%)

SDC SmileDirectClub
$5.53 /

-0.21 (-3.66%)

PHAS PhaseBio
$3.98 /

-0.02 (-0.50%)

NYT New York Times
$53.15 /

-1.16 (-2.14%)

MSTR MicroStrategy
$750.46 /

+24.31 (+3.35%)

FUV Arcimoto
$10.33 /

-0.17 (-1.62%)

BGFV Big 5 Sporting
$23.95 /

-0.06 (-0.25%)

SDC SmileDirectClub
$5.53 /

-0.21 (-3.66%)

MSTR MicroStrategy
$750.46 /

+24.31 (+3.35%)

FUV Arcimoto
$10.33 /

-0.17 (-1.62%)

BGFV Big 5 Sporting
$23.95 /

-0.06 (-0.25%)

On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:16
10/15/21
10/15
16:16
10/15/21
16:16
GS

Goldman Sachs

$406.00 /

+14.685 (+3.75%)

, SPCE

Virgin Galactic

$20.00 /

-4.06 (-16.87%)

, MRNA

Moderna

$324.02 /

-7.73 (-2.33%)

, AA

Alcoa

$55.98 /

+7.39 (+15.21%)

, JNJ

Johnson & Johnson

$161.35 /

+1.27 (+0.79%)

, AVGO

Broadcom

$503.23 /

+5.58 (+1.12%)

, WDC

Western Digital

$55.45 /

-1.1 (-1.95%)

, MS

Morgan Stanley

$102.09 /

+0.99 (+0.98%)

, SQSP

Squarespace

$38.39 /

+1.95 (+5.35%)

, BITCOIN

Bitcoin

/

+

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

, FB

Facebook

$324.80 /

-3.63 (-1.11%)

, AAPL

Apple

$144.79 /

+1.04 (+0.72%)

, DIS

Disney

$176.46 /

+1.97 (+1.13%)

, AZN

AstraZeneca

$60.22 /

+0.52 (+0.87%)

, ME

23andMe

$9.20 /

+1.325 (+16.84%)

, FUBO

FuboTV

$28.02 /

+0.33 (+1.19%)

, JBHT

J.B. Hunt

$190.45 /

+15.285 (+8.73%)

, TRQ

Turquoise Hill

$13.12 /

-2.3 (-14.92%)

, DCT

Duck Creek Technologies

$34.94 /

-11.3 (-24.44%)

, PNC

PNC Financial

$199.10 /

-3.46 (-1.71%)

, SCHW

Charles Schwab

$80.89 /

+2.75 (+3.52%)

, PLD

Prologis

$137.00 /

+1.27 (+0.94%)

, ADTN

Adtran

$18.21 /

-0.87 (-4.56%)

, TFC

Truist Financial

$61.37 /

+0.73 (+1.20%)

Get caught up quickly on…

ShowHide Related Items >><<
WDC Western Digital
$55.45 /

-1.1 (-1.95%)

TRQ Turquoise Hill
$13.12 /

-2.3 (-14.92%)

TFC Truist Financial
$61.37 /

+0.73 (+1.20%)

SQSP Squarespace
$38.39 /

+1.95 (+5.35%)

SPCE Virgin Galactic
$20.00 /

-4.06 (-16.87%)

SCHW Charles Schwab
$80.89 /

+2.75 (+3.52%)

PNC PNC Financial
$199.10 /

-3.46 (-1.71%)

PLD Prologis
$137.00 /

+1.27 (+0.94%)

MS Morgan Stanley
$102.09 /

+0.99 (+0.98%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

ME 23andMe
$9.20 /

+1.325 (+16.84%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

JBHT J.B. Hunt
$190.45 /

+15.285 (+8.73%)

GS Goldman Sachs
$406.00 /

+14.685 (+3.75%)

FUBO FuboTV
$28.02 /

+0.33 (+1.19%)

FB Facebook
$324.80 /

-3.63 (-1.11%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

DCT Duck Creek Technologies
$34.94 /

-11.3 (-24.44%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

AVGO Broadcom
$503.23 /

+5.58 (+1.12%)

ADTN Adtran
$18.21 /

-0.87 (-4.56%)

AAPL Apple
$144.79 /

+1.04 (+0.72%)

AA Alcoa
$55.98 /

+7.39 (+15.21%)

GS Goldman Sachs
$406.00 /

+14.685 (+3.75%)

10/01/21 Citi
Goldman Sachs price target raised to $440 from $410 at Citi
09/29/21 Oppenheimer
Morgan Stanley downgraded to Perform at Oppenheimer on valuation
07/14/21 Oppenheimer
Goldman Sachs price target raised to $540 from $493 at Oppenheimer
07/14/21 Credit Suisse
Goldman Sachs price target raised to $425 from $420 at Credit Suisse
SPCE Virgin Galactic
$20.00 /

-4.06 (-16.87%)

10/15/21 Canaccord
Virgin Galactic flight delay not significant to long-term plans, says Canaccord
10/15/21 BofA
Virgin Galactic price target lowered to $20 from $25 at BofA
09/16/21 Cowen
Virgin Galactic price target lowered to $30 from $51 at Cowen
09/14/21 UBS
Virgin Galactic price target lowered to $26 from $38 at UBS
MRNA Moderna
$324.02 /

-7.73 (-2.33%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
AA Alcoa
$55.98 /

+7.39 (+15.21%)

10/15/21 B. Riley
Alcoa price target raised to $52 from $51 at B. Riley
09/28/21 Morgan Stanley
Morgan Stanley raises Alcoa price target to $62, names stock Top Pick
09/21/21 B. Riley
Alcoa price target raised to $51 from $45 at B. Riley
09/16/21 Deutsche Bank
Alcoa price target raised to $60 from $48 at Deutsche Bank
JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
AVGO Broadcom
$503.23 /

+5.58 (+1.12%)

10/14/21 Goldman Sachs
Broadcom upgraded to Buy from Neutral at Goldman Sachs
10/13/21 Gordon Haskett
Gordon Haskett calls Citrix sort of business Broadcom 'finds appealing'
10/13/21 BofA
Cirrus, Skyworks among chip vendors with highest iPhone cut exposure, says BofA
WDC Western Digital
$55.45 /

-1.1 (-1.95%)

10/15/21
Fly Intel: Top five analyst downgrades
10/14/21 Goldman Sachs
Western Digital downgraded to Neutral from Buy at Goldman Sachs
10/12/21 Lynx
Lynx still bearish on Micron, would not be stepping in on long side
09/16/21 Benchmark
Seagate, Western Digital weakness not supported by commentary, says Benchmark
MS Morgan Stanley
$102.09 /

+0.99 (+0.98%)

10/15/21 BMO Capital
Morgan Stanley price target raised to $109 from $107 at BMO Capital
10/15/21 Piper Sandler
Morgan Stanley price target raised to $110 from $103 at Piper Sandler
10/15/21 Barclays
Morgan Stanley price target raised to $110 from $98 at Barclays
SQSP Squarespace
$38.39 /

+1.95 (+5.35%)

10/15/21 Piper Sandler
Squarespace upgraded to Overweight from Neutral at Piper Sandler
08/10/21 KeyBanc
Squarespace price target lowered to $60 from $70 at KeyBanc
08/10/21 Barclays
Squarespace price target lowered to $62 from $70 at Barclays
BITCOIN Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
BTC Bitcoin
/

+

04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
$BTC Bitcoin
/

+

FB Facebook
$324.80 /

-3.63 (-1.11%)

10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
10/07/21 JPMorgan
Negative Facebook news flow seen before, buy the selloff, says JPMorgan
AAPL Apple
$144.79 /

+1.04 (+0.72%)

10/15/21 Evercore ISI
Evercore ISI thinks Apple can become 'serious player in the advertising market'
10/14/21 Needham
Needham cuts Apple iPhone 13 shipment estimates for calendar Q4
10/14/21 Citi
Apple likely to sound more cautious due to supply chain, says Citi
DIS Disney
$176.46 /

+1.97 (+1.13%)

09/28/21 Wells Fargo
Wells Fargo cuts Disney target, sees 'wood to chop' to hit sub outlook
09/22/21 BofA
Disney's Q4 Disney+ subscriber adds estimate cut to 2M from 14M at BofA
09/21/21 KeyBanc
Disney+ subscriber guidance 'a very modest incremental negative,' says KeyBanc
09/21/21 Daiwa
Disney initiated with a Buy at Daiwa
AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
09/28/21 Oppenheimer
Zentalis initiated with an Outperform at Oppenheimer
ME 23andMe
$9.20 /

+1.325 (+16.84%)

08/16/21 Credit Suisse
23andMe initiated with an Outperform at Credit Suisse
08/16/21 Citi
23andMe price target lowered to $12 from $14 at Citi
07/13/21 Citi
23andMe initiated with a Buy at Citi
FUBO FuboTV
$28.02 /

+0.33 (+1.19%)

08/11/21 Evercore ISI
FuboTV price target raised to $40 from $30 at Evercore ISI
08/11/21 BMO Capital
FuboTV price target raised to $30 from $25 at BMO Capital
08/10/21 Oppenheimer
Golden Nugget Online acquisition opens up new customer base, says Oppenheimer
07/16/21 Roth Capital
FuboTV sportsbook license count up to four after Cordish deal, says Roth Capital
JBHT J.B. Hunt
$190.45 /

+15.285 (+8.73%)

10/11/21 Vertical Research
J.B. Hunt downgraded to Hold from Buy at Vertical Research
10/08/21
Fly Intel: Top five analyst downgrades
10/08/21 JPMorgan
J.B. Hunt downgraded to Underweight on relative valuation at JPMorgan
10/08/21 JPMorgan
J.B. Hunt downgraded to Underweight from Neutral at JPMorgan
TRQ Turquoise Hill
$13.12 /

-2.3 (-14.92%)

10/15/21 BMO Capital
Turquoise Hill price target lowered to C$17 from C$20 at BMO Capital
10/15/21 TD Securities
Turquoise Hill downgraded to Hold from Speculative Buy at TD Securities
10/15/21 Scotiabank
Turquoise Hill downgraded to Sector Perform from Outperform at Scotiabank
10/15/21 BMO Capital
Turquoise Hill price target lowered to C$17 from C$20 at BMO Capital
DCT Duck Creek Technologies
$34.94 /

-11.3 (-24.44%)

10/15/21 JPMorgan
JPMorgan downgrades Duck Creek on thesis 'cracks' post results
10/15/21 RBC Capital
Duck Creek Technologies price target lowered to $47 from $51 at RBC Capital
10/15/21 JPMorgan
Duck Creek Technologies downgraded to Neutral from Overweight at JPMorgan
PNC PNC Financial
$199.10 /

-3.46 (-1.71%)

10/15/21 BofA
PNC Financial downgraded to Neutral from Buy at BofA
10/11/21 Jefferies
PNC Financial price target raised to $221 from $201 at Jefferies
10/01/21 Citi
PNC Financial downgraded to Neutral from Buy at Citi
07/19/21 Odeon Capital
PNC Financial downgraded to Hold from Buy at Odeon Capital
SCHW Charles Schwab
$80.89 /

+2.75 (+3.52%)

10/05/21
Fly Intel: Top five analyst initiations
10/05/21 Atlantic Equities
Atlantic Equities starts 'asset-gathering machine' Charles Schwab at Overweight
10/05/21 Atlantic Equities
Charles Schwab initiated with an Overweight at Atlantic Equities
07/23/21 Deutsche Bank
Charles Schwab price target raised to $92 from $90 at Deutsche Bank
PLD Prologis
$137.00 /

+1.27 (+0.94%)

10/08/21 BTIG
Prologis price target raised to $146 from $121 at BTIG
09/20/21
Fly Intel: Top five analyst downgrades
09/20/21 Evercore ISI
Prologis downgraded to In Line from Outperform at Evercore ISI
09/01/21 Barclays
Prologis initiated with an Overweight at Barclays
ADTN Adtran
$18.21 /

-0.87 (-4.56%)

08/31/21 Northland
Northland ups Adtran target, calls ADVA combo 'unexpected but attractive'
08/06/21 Cowen
Adtran upgraded to Outperform from Market Perform at Cowen
08/06/21 Cowen
Adtran upgraded to Outperform from Market Perform at Cowen
06/08/21 Jefferies
Telecom capex spending environment improving modestly, says Jefferies
TFC Truist Financial
$61.37 /

+0.73 (+1.20%)

10/11/21 Jefferies
Truist Financial price target raised to $66 from $61 at Jefferies
10/05/21 Wolfe Research
Truist downgraded to Underperform from Outperform at Wolfe Research
10/01/21 Citi
Truist Financial upgraded to Buy from Neutral at Citi
07/19/21 Odeon Capital
Truist Financial downgraded to Hold from Buy at Odeon Capital
WDC Western Digital
$55.45 /

-1.1 (-1.95%)

TRQ Turquoise Hill
$13.12 /

-2.3 (-14.92%)

TFC Truist Financial
$61.37 /

+0.73 (+1.20%)

SQSP Squarespace
$38.39 /

+1.95 (+5.35%)

SPCE Virgin Galactic
$20.00 /

-4.06 (-16.87%)

SCHW Charles Schwab
$80.89 /

+2.75 (+3.52%)

PNC PNC Financial
$199.10 /

-3.46 (-1.71%)

PLD Prologis
$137.00 /

+1.27 (+0.94%)

MS Morgan Stanley
$102.09 /

+0.99 (+0.98%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

ME 23andMe
$9.20 /

+1.325 (+16.84%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

JBHT J.B. Hunt
$190.45 /

+15.285 (+8.73%)

GS Goldman Sachs
$406.00 /

+14.685 (+3.75%)

FUBO FuboTV
$28.02 /

+0.33 (+1.19%)

FB Facebook
$324.80 /

-3.63 (-1.11%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

DCT Duck Creek Technologies
$34.94 /

-11.3 (-24.44%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

AVGO Broadcom
$503.23 /

+5.58 (+1.12%)

ADTN Adtran
$18.21 /

-0.87 (-4.56%)

AAPL Apple
$144.79 /

+1.04 (+0.72%)

AA Alcoa
$55.98 /

+7.39 (+15.21%)

  • 19
    May
  • 29
    Jan
  • 30
    Dec
  • 11
    Nov
WDC Western Digital
$55.45 /

-1.1 (-1.95%)

SPCE Virgin Galactic
$20.00 /

-4.06 (-16.87%)

SCHW Charles Schwab
$80.89 /

+2.75 (+3.52%)

PNC PNC Financial
$199.10 /

-3.46 (-1.71%)

MS Morgan Stanley
$102.09 /

+0.99 (+0.98%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

JBHT J.B. Hunt
$190.45 /

+15.285 (+8.73%)

GS Goldman Sachs
$406.00 /

+14.685 (+3.75%)

FUBO FuboTV
$28.02 /

+0.33 (+1.19%)

FB Facebook
$324.80 /

-3.63 (-1.11%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

BITCOIN Bitcoin
/

+

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

AVGO Broadcom
$503.23 /

+5.58 (+1.12%)

AAPL Apple
$144.79 /

+1.04 (+0.72%)

AA Alcoa
$55.98 /

+7.39 (+15.21%)

WDC Western Digital
$55.45 /

-1.1 (-1.95%)

TRQ Turquoise Hill
$13.12 /

-2.3 (-14.92%)

TFC Truist Financial
$61.37 /

+0.73 (+1.20%)

SQSP Squarespace
$38.39 /

+1.95 (+5.35%)

SPCE Virgin Galactic
$20.00 /

-4.06 (-16.87%)

PNC PNC Financial
$199.10 /

-3.46 (-1.71%)

PLD Prologis
$137.00 /

+1.27 (+0.94%)

MS Morgan Stanley
$102.09 /

+0.99 (+0.98%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

ME 23andMe
$9.20 /

+1.325 (+16.84%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

JBHT J.B. Hunt
$190.45 /

+15.285 (+8.73%)

GS Goldman Sachs
$406.00 /

+14.685 (+3.75%)

FUBO FuboTV
$28.02 /

+0.33 (+1.19%)

FB Facebook
$324.80 /

-3.63 (-1.11%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

DCT Duck Creek Technologies
$34.94 /

-11.3 (-24.44%)

BITCOIN Bitcoin
/

+

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

AVGO Broadcom
$503.23 /

+5.58 (+1.12%)

ADTN Adtran
$18.21 /

-0.87 (-4.56%)

AAPL Apple
$144.79 /

+1.04 (+0.72%)

AA Alcoa
$55.98 /

+7.39 (+15.21%)

WDC Western Digital
$55.45 /

-1.1 (-1.95%)

TRQ Turquoise Hill
$13.12 /

-2.3 (-14.92%)

SQSP Squarespace
$38.39 /

+1.95 (+5.35%)

SPCE Virgin Galactic
$20.00 /

-4.06 (-16.87%)

SCHW Charles Schwab
$80.89 /

+2.75 (+3.52%)

MS Morgan Stanley
$102.09 /

+0.99 (+0.98%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

ME 23andMe
$9.20 /

+1.325 (+16.84%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

JBHT J.B. Hunt
$190.45 /

+15.285 (+8.73%)

GS Goldman Sachs
$406.00 /

+14.685 (+3.75%)

FUBO FuboTV
$28.02 /

+0.33 (+1.19%)

FB Facebook
$324.80 /

-3.63 (-1.11%)

DIS Disney
$176.46 /

+1.97 (+1.13%)

DCT Duck Creek Technologies
$34.94 /

-11.3 (-24.44%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

AVGO Broadcom
$503.23 /

+5.58 (+1.12%)

AAPL Apple
$144.79 /

+1.04 (+0.72%)

AA Alcoa
$55.98 /

+7.39 (+15.21%)

AAPL Apple
$144.79 /

+1.04 (+0.72%)

Periodicals
AstraZeneca wins ruling upholding Farziga patent, Bloomberg says » 15:30
10/15/21
10/15
15:30
10/15/21
15:30
AZN

AstraZeneca

$60.21 /

+0.51 (+0.85%)

AstraZeneca has won a…

AstraZeneca has won a federal court ruling upholding a significant patent for Farxiga, its diabetes treatment, warding off threats from cheaper drugs, Bloomberg's Christopher Yasiejko reports. A trial without a jury earlier this year centered on the validity of a patent that covers the drug's active ingredient, dapagliflozin, its combination with a carrier and methods of treatment, the author says. Reference Link

ShowHide Related Items >><<
AZN AstraZeneca
$60.21 /

+0.51 (+0.85%)

AZN AstraZeneca
$60.21 /

+0.51 (+0.85%)

10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
09/28/21 Oppenheimer
Zentalis initiated with an Outperform at Oppenheimer
AZN AstraZeneca
$60.21 /

+0.51 (+0.85%)

AZN AstraZeneca
$60.21 /

+0.51 (+0.85%)

AZN AstraZeneca
$60.21 /

+0.51 (+0.85%)

AZN AstraZeneca
$60.21 /

+0.51 (+0.85%)

Periodicals
AstraZeneca wins ruling upholding Farziga patent, Bloomberg says  15:01
10/15/21
10/15
15:01
10/15/21
15:01
AZN

AstraZeneca

$60.23 /

+0.53 (+0.89%)

 
ShowHide Related Items >><<
AZN AstraZeneca
$60.23 /

+0.53 (+0.89%)

AZN AstraZeneca
$60.23 /

+0.53 (+0.89%)

10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
09/28/21 Oppenheimer
Zentalis initiated with an Outperform at Oppenheimer
AZN AstraZeneca
$60.23 /

+0.53 (+0.89%)

AZN AstraZeneca
$60.23 /

+0.53 (+0.89%)

AZN AstraZeneca
$60.23 /

+0.53 (+0.89%)

AZN AstraZeneca
$60.23 /

+0.53 (+0.89%)

Hot Stocks
Synlogic presents data on hyperoxaluria program » 10:32
10/15/21
10/15
10:32
10/15/21
10:32
SYBX

Synlogic

$2.74 /

+0.04 (+1.48%)

Synlogic announced two…

Synlogic announced two poster presentations at the upcoming American Society for Nephrology Kidney Week 2021, to be held virtually November 4 - 7th, 2021. The two posters will be available throughout the duration of the conference: Poster #3605649: Relationship Between 24-hr Urinary Oxalate and Incident Chronic Kidney Disease Among Patients with and without Underlying Gastrointestinal Disease: In one of the largest longitudinal retrospective observational cohort studies of urinary oxalate to date, greater than750,000 individuals with at least one 24-hr urine collection were identified. The risk of incident chronic kidney disease increased with increasing 24-hour urine oxalate excretion, with an odds ratio of 1.67 for the highest UOx group compared with the lowest UOx group. Poster #3605510: Proof-of-Concept Study of Oxalate-Consuming Synthetic Biotic Medicine SYNB8802 in Enteric Hyperoxaluria after Roux-en-Y Surgery: As previously disclosed, the dose of 3e11 live cells was identified in healthy volunteers and demonstrated to be well-tolerated. At this dose, the percent reduction from baseline UOx levels was -28.6% compared to placebo in diet-induced hyperoxaluria. Part B of the study is a double-blind, placebo-controlled crossover study of SYNB8802 in subjects with enteric hyperoxaluria and a history of Roux-en-Y gastric bypass surgery. Part B remains ongoing and results are expected in 2022.

ShowHide Related Items >><<
SYBX Synlogic
$2.74 /

+0.04 (+1.48%)

SYBX Synlogic
$2.74 /

+0.04 (+1.48%)

10/13/21 H.C. Wainwright
Synlogic price target lowered to $7 from $9 at H.C. Wainwright
09/20/21 Chardan
Synlogic phenylketonuria data 'encouraging,' says Chardan
09/20/21 Piper Sandler
Synlogic price target raised to $9 at Piper Sandler on positive SynPHEny data
07/09/21 Chardan
Synlogic assumed with a Buy at Chardan
SYBX Synlogic
$2.74 /

+0.04 (+1.48%)

  • 23
    Sep
  • 16
    Apr
SYBX Synlogic
$2.74 /

+0.04 (+1.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.